High Serum CEA and CYFRA21-1 Levels after a Two-Cycle Adjuvant Chemotherapy for NSCLC: Possible Poor Prognostic Factors

High Serum CEA and CYFRA21-1 Levels after a Two-Cycle Adjuvant Chemotherapy for NSCLC: Possible Poor Prognostic Factors

<b>Objective</b> The aim of this study was to test whether carcinoembryonic antigen (CEA) and cytokeratin 19 fragments (CYFRA21-1) can be used as a prognostic factor for non-small-cell lung cancer (NSCLC) after two cycles of adjuvant chemotherapy in NSCLC patients.<br><b>Meth...

Full description

Bibliographic Details
Main Authors: Xue-feng Lin, Xiao-dong Wang, Da-qiang Sun, Zhi Li, Yue Bai
Format: Article
Language:English
Published: China Anti-Cancer Association 2012-12-01
Series:Cancer Biology & Medicine
Subjects:
non-small-cell lung cancer
carcinoembryonic antigen
cytokeratin 19 fragement
adjuvant chemotherapy
prognosis
Online Access:http://www.cancerbiomed.org/index.php/cocr/article/view/377

Internet

http://www.cancerbiomed.org/index.php/cocr/article/view/377

Similar Items